University of Hertfordshire Research Archive

        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UHRABy Issue DateAuthorsTitlesThis CollectionBy Issue DateAuthorsTitles

        Arkivum Files

        My Downloads
        View Item 
        • UHRA Home
        • University of Hertfordshire
        • Research publications
        • View Item
        • UHRA Home
        • University of Hertfordshire
        • Research publications
        • View Item

        Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature

        View/Open
        Final Published version (PDF, 2Mb)
        Author
        Martinotti, Giovanni
        Chiappini, Stefania
        Pettorruso, Mauro
        Mosca, Alessio
        Miuli, Andrea
        Di Carlo, Francesco
        D’Andrea, Giacomo
        Collevecchio, Roberta
        Di Muzio, Ilenia
        Sensi, Stefano L.
        Di Giannantonio, Massimo
        Attention
        2299/25016
        Abstract
        The obsessive–compulsive spectrum refers to disorders drawn from several diagnostic categories that share core features related to obsessive–compulsive disorder (OCD), such as obsessive thoughts, compulsive behaviors and anxiety. Disorders that include these features can be grouped according to the focus of the symptoms, e.g., bodily preoccupation (i.e., eating disorders, ED) or impulse control (i.e., substance use disorders, SUD), and they exhibit intriguing similarities in phenomenology, etiology, pathophysiology, patient characteristics and clinical outcomes. The non-competitive N-methyl-D-aspartate receptor (NMDAr) antagonist ketamine has been indicated to produce remarkable results in patients with treatment-resistant depression, post-traumatic stress disorder and OCD in dozens of small studies accrued over the past decade, and it appears to be promising in the treatment of SUD and ED. However, despite many small studies, solid evidence for the benefits of its use in the treatment of OCD spectrum and addiction is still lacking. Thus, the aim of this perspective article is to examine the potential for ketamine and esketamine in treating OCD, ED and SUD, which all involve recurring and intrusive thoughts and generate associated compulsive behavior. A comprehensive and updated overview of the literature regarding the pharmacological mechanisms of action of both ketamine and esketamine, as well as their therapeutic advantages over current treatments, are provided in this paper. An electronic search was performed, including all papers published up to April 2021, using the following keywords (“ketamine” or “esketamine”) AND (“obsessive” OR “compulsive” OR “OCD” OR “SUD” OR “substance use disorder” OR “addiction” OR “craving” OR “eating” OR “anorexia”) NOT review NOT animal NOT “in vitro”, on the PubMed, Cochrane Library and Web of Science online databases. The review was conducted in accordance with preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. The use and efficacy of ketamine in SUD, ED and OCD is supported by glutamatergic neurotransmission dysregulation, which plays an important role in these conditions. Ketamine’s use is increasing, and preliminary data are optimistic. Further studies are needed in order to better clarify the many unknowns related to the use of both ketamine and esketamine in SUD, ED and OCD, and to understand their long-term effectiveness.
        Publication date
        2021-06-27
        Published in
        Brain Sciences
        Published version
        https://doi.org/10.3390/brainsci11070856
        License
        http://creativecommons.org/licenses/by/4.0/
        Other links
        http://hdl.handle.net/2299/25016
        Relations
        School of Life and Medical Sciences
        Metadata
        Show full item record

        Related items

        Showing items related by title, author, creator and subject.

        • Lifetime Bipolar Disorder comorbidity and related clinical characteristics in patients with primary Obsessive Compulsive Disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 

          Dell'Osso, Bernado; Vismara, Matteo; Benatti, Beatrice; Cirnigliaro, Giovanna; Grancini, Benedetta; Fineberg, Naomi; Van Ameringen, Michael; Hollander, Eric; Stein, Dan J.; Menchon, Josè M; Rodriguez, Carolyn I; Nicolini, Humberto; Lanzagorta, Nuria; Pallanti, Stefano; Grassi, Giacomo; Lochner, Christine; Marazziti, Donatella; Hranov, Georgi; Karamustafalioglu, Oguz; Hranov, Luchezar; Zohar, Joseph (2019-05-27)
          IntroductionBipolar disorder (BD) and obsessive compulsive disorder (OCD) are prevalent, comorbid, and disabling conditions, often characterized by early onset and chronic course. When comorbid, OCD and BD can determine a ...
        • How to manage obsessive-compulsive disorder (OCD) under COVID-19 : A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology 

          Fineberg, Naomi; Van Ameringen, Michael; Drummond, L.; Hollander, Eric; Stein, D.J.; Geller, Daniel; Walitza, Susanne; Pallanti, Stefano; Pellegrini, Lucas; Zohar, Joseph; Rodriguez, C I; Menchon, Josè M; Morgado, Pedro; Mpavaenda, Davis; Fontenelle, Leonardo F.; Feusner, J D; Grassi, Giacomo; Lochner, Christine; Veltman, Dick J.; Sireau, Nick; Carmi, Lior; Adam, D; Nicolini, Humberto; Dell'Osso, Bernardo (2020-04-12)
        • Empathy Dysfunction: Deconstructing social functioning in Autism Spectrum Disorders and Conduct Disorder 

          Ludlow, Amanda; Reniers, Renate; Vilas Sanz, Sara (Nova Science Publishers, 2016-02-01)
          Empathy is a multidimensional construct that can be understood as the ability to be perceptive of and vicariously experience the feelings of other people (affective components of empathy), while at the same time being able ...
        Keep in touch

        © 2019 University of Hertfordshire

        I want to...

        • Apply for a course
        • Download a Prospectus
        • Find a job at the University
        • Make a complaint
        • Contact the Press Office

        Go to...

        • Accommodation booking
        • Your student record
        • Bayfordbury
        • KASPAR
        • UH Arts

        The small print

        • Terms of use
        • Privacy and cookies
        • Criminal Finances Act 2017
        • Modern Slavery Act 2015
        • Sitemap

        Find/Contact us

        • T: +44 (0)1707 284000
        • E: ask@herts.ac.uk
        • Where to find us
        • Parking
        • hr
        • qaa
        • stonewall
        • AMBA
        • ECU Race Charter
        • disability confident
        • AthenaSwan